StockNews.com initiated coverage on shares of Dyne Therapeutics (NYSE:DYN – Get Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock.
Dyne Therapeutics Trading Down 6.4 %
NYSE DYN opened at $12.63 on Thursday. Dyne Therapeutics has a 12-month low of $4.30 and a 12-month high of $15.63.
- Get a free copy of the StockNews.com research report on Dyne Therapeutics (DYN)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for Dyne Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyne Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.